高尿酸血症(Hyperuricemia):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIIR2016305)
◆英語タイトル:Hyperuricemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018
◆発行会社/調査会社:DelveInsight
◆商品コード:DIIR2016305
◆発行日:2019年04月
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約100
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD2,000 ⇒換算¥218,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD6,000 ⇒換算¥654,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[高尿酸血症(Hyperuricemia):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)]についてメールでお問い合わせはこちら
※当調査レポートでは、高尿酸血症(Hyperuricemia)治療薬の世界市場動向について調査・分析し、以下の構成でお届けいたします。

・高尿酸血症(Hyperuricemia):適応症(疾患)の概要
・市販医薬品の状況
・世界のAPI(医薬品原薬)メーカー分析
・地域別APIメーカー状況(アメリカ、ヨーロッパ、中国など)
・高尿酸血症(Hyperuricemia)のフェーズ3治験薬の状況
・高尿酸血症(Hyperuricemia)治療薬の市場規模(販売予測)
・高尿酸血症(Hyperuricemia)の市販医薬品分析
 (医薬品名、説明、APIメーカー、承認状況、特許など)
・高尿酸血症(Hyperuricemia)のフェーズ3治験薬分析
・開発中止中の高尿酸血症(Hyperuricemia)治療薬剤
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s Report, “Hyperuricemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hyperuricemia Report is to understand the market and pipeline status of the drugs around the Hyperuricemia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2020. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Hyperuricemia. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight’s report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


SCOPE:
• A snapshot of the global Market and Phase III therapeutics scenario for Hyperuricemia.
• A review of the marketed products under prescription for Hyperuricemia, regulatory information and marketing status.
• Coverage of global patent coverage and detailed commentaries on the US patent challenges.
• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
• Product profiles for marketed products for Hyperuricemia with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
• Coverage of API Manufacturers for Hyperuricemia drugs in the United States, Europe and Asian Regions with location details.
• Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Hyperuricemia drugs.
• Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Hyperuricemia drugs.
• Coverage of Hyperuricemia Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
• Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
• Key discontinued Marketed products.
• Global Sales Figure to 2020.


*** レポート目次(コンテンツ)***

1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2020
6. Marketed Drugs for Hyperuricemia
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for Hyperuricemia
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for Hyperuricemia
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer

List of Tables
• Hyperuricemia Therapeutic Market, US, Marketed Drugs by Application Type, 2018
• Hyperuricemia Therapeutic Market, US, Marketed Drugs by Marketing Status, 2018
• Hyperuricemia Therapeutic Market, US, (Year), 2018
• Hyperuricemia Marketed Drugs, API Manufacturers by US DMF Status, 2018
• Hyperuricemia Marketed Drugs, US DMF Status Drug Specific (Number), 2018
• Hyperuricemia Drugs, API Manufacturers, Europe by Country, 2018
• Hyperuricemia Drugs, API Manufacturers, India by State, 2018
• Hyperuricemia Drugs, API Manufacturers, China by Province, 2018
• Hyperuricemia Drugs, API Manufacturers by Geography 2018
• Hyperuricemia Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2018
• Hyperuricemia Therapeutic Market, Global Sales-2020 (in million USD)
• API Manufacturers for Drug, 2018
• Phase III Drugs for Hyperuricemia, 2018
• Discontinued Drugs for Hyperuricemia, 2018


List of Figures
• Hyperuricemia Therapeutic Market, US, Marketed Drugs by Application Type (%), 2018
• Hyperuricemia Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2018
• Hyperuricemia Therapeutic Market, US, (Year), 2018
• Hyperuricemia Marketed Drugs, API Manufacturers by US DMF Status (%), 2018
• Hyperuricemia Marketed Drugs, US DMF Status Drug Specific (Number), 2018
• Hyperuricemia Drugs, API Manufacturers, Europe by Country, 2018
• Hyperuricemia Drugs, API Manufacturers, India by State, 2018
• Hyperuricemia Drugs, API Manufacturers, China by Province, 2018
• Hyperuricemia Drugs, API Manufacturers by Geography 2018
• Hyperuricemia Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2018
• Hyperuricemia Therapeutic Market, Global Sales 2020 (in million USD)
• Drug, Patent/Exclusivity Expiry (Year), 2018


*** レポートのキーワード ***

高尿酸血症(Hyperuricemia)、薬剤、治療薬、市場規模、販売量、医薬品有効成分(API)メーカー、治験、上市品(市販薬)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 風力発電用ブレードの世界市場
    In this report, the global Wind power blades market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue …
  • 有機食用油の世界市場:販売動向2018
    This report studies the global Organic Edible Oil market status and forecast, categorizes the global Organic Edible Oil market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and …
  • 世界及び中国のトリヒドロキシアルミニウム市場2016
    The 'Global and Chinese Aluminium Hydroxide Acetate Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Aluminium Hydroxide Acetate industry with a focus on the Chinese market. The report provides key statistics on the market status of …
  • イースト(酵母)市場(~2019):ネパール
    The industry report Yeast Market in Nepal to 2019 offers the most up-to-date market data on the actual market situation, and future outlook for yeasts in Nepal. The research includes historic market data from 2008 to 2014 and forecasts until 2019 which makes the report an invaluable resource for ind …
  • 世界及び中国の炭酸水銀市場2009-2019
    Market Research Report on Global and Chinese Mercury carbonate Industry, 2009-2019 is a professional and in-depth market survey on Global and Chinese Mercury carbonate industry. The report firstly reviews the basic information of Mercury carbonate including its classification, application and manufa …
  • Valouro – Poultry and FEED Production Plant – Mozambique:建設プロジェクト概要
    World Market Intelligence's "Valouro – Poultry and FEED Production Plant – Mozambique - Construction Project Profile" is a crucial resource for industry executives and anyone looking to access key information about the Valouro – Poultry and FEED Production Plant – Mozambique construction project. Wo …
  • タイのビスフェノールA市場2016-2020
    About The report brings together facts and figures about bisphenol a market in Thailand covering period of 2009-2019. Statistics, experts’ opinions and estimations are given. The report about bisphenol a market in Thailand covers: - manufacturers capacity, production volumes - company profiles - con …
  • シート(家具)市場(規模、動向、予測):アフリカ
    This industry report package offers the most up-to-date market data on the actual market situation, trends, and future outlook for seats in different African countries. The package includes seat country reports from the following countries: Botswana, Ethiopia, Ghana, Kenya, Morocco, Nigeria, Rwanda, …
  • Database of Confectionery and Nut Stores in Canada
    This company database includes the details of nearly 1000 confectionery and nut stores in Canada. The database contains the following information about the companies: Company name Contact details Contact persons Financial information Number of employees The database is designed for companies who wan …
  • A型インフルエンザウイルス感染症:世界の治験レビュー(2017年下半期版)
    Influenzavirus A Infections Global Clinical Trials Review, H2, 2017 Summary GlobalData's clinical trial report, “Influenzavirus A Infections Global Clinical Trials Review, H2, 2017" provides an overview of Influenzavirus A Infections clinical trials scenario. This report provides top line data relat …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIIR2016305 )"高尿酸血症(Hyperuricemia):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)" (英文:Hyperuricemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。